Report- Botulinum Toxin Market 2017-2021 | Page 3

Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Key market highlights PART 05: Botulinum toxin: An overview PART 06: Pipeline landscape PART 07: Market landscape • Five forces analysis PART 08: Market segmentation by drug categories • Aesthetic drugs market • Therapeutic drugs market PART 09: Geographical segmentation • Botulinum toxin market in Americas • Botulinum toxin market in EMEA • Botulinum toxin market in APAC PART 10: Decision framework PART 11: Drivers and challenges • Market drivers • Impact of drivers on key customer segments • Market challenges • Impact of challenges on key customer segments PART 12: Market trends • Growing importance of medical aesthetics • Technological advancement • Growing demand for anti-aging treatment PART 13: Vendor landscape • Competitive landscape • Key news PART 14: Key vendor analysis • ALLERGAN • Galderma • Ipsen • Merz Pharma • Pfizer • Other prominent vendors PART 15: Appendix • List of abbreviations List of Exhibits Exhibit 01: Pipeline landscape Exhibit 02: Global botulinum toxin market: Snapshot Exhibit 03: Global botulinum toxin market 2016-2021 ($ millions) Exhibit 04: Global botulinum toxin market: Opportunity analysis Exhibit 05: Five forces analysis Exhibit 06: Market segmentation by drug category 2016 Exhibit 07: Global aesthetic drugs market 2016-2021 ($ millions) Exhibit 08: Global therapeutic drugs market 2016-2021 ($ millions) Exhibit 09: Segmentation of global botulinum toxin market based on geography 2016 and 2021 Exhibit 10: Global botulinum toxin market revenue by geography 2016-2021 ($ millions)